Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $3.59 Analyst target: $17.11 Upside: 376.60%
Wave Life Sciences Ltd., a clinical-stage genetic medicine company, designs, optimizes and produces new stereopure oligonucleotides through PRISM, a drug discovery and development platform. The company is headquartered in Singapore.
See the full interactive analysis & chart →Informational only — not investment advice.